Clinical Trials Browser

Fallopian Tube Neoplasms × Injections × 90 days × Clear all

NCT06173037 2026-01-07

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06545617 2026-01-07

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Phase 1/2 Withdrawn

Fallopian Tube Neoplasms